In partial support, induction of endogenous GDF15 by the liver reduced phenotypes associated with hepatic steatosis in mouse models, and thus was suggested to be a compensatory mechanism to cope with metabolic deterioration (Kim, Kim, et al., 2018). This evidence concerns the gene GDF15 and fatty liver disease.